Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypochlorous Acid vs Polyhexamethylene Biguanide for Diabetic Foot Ulcers
2024-512612-22-00Phase 3Authorised
- Sponsor
- Region Västra Götaland
- Start
- Nov 2024
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic foot ulcer (DFU) comparing Hypochlorous acid arm with Polyhexamethylene biguanide arm (2 arms). Primary endpoint: Time to diabetic foot ulcer healing. Planned start Nov 2024; status: authorised.
02
Drugs
hypochlorous acidpolihexanide
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on 2024-512612-22-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512612-22-00.